Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)

NCT05698316 is registered in ClinicalTrials.gov with Association for Innovation and Biomedical Research on Light and Image as lead sponsor.

NCT NCT05698316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05698316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)
Lead sponsor
Association for Innovation and Biomedical Research on Light and Image
Phase
Observational
Overall status
Completed
Start date
May 4, 2023
Completion date
December 31, 2025
Enrollment
1,000 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, atrophy, intermediate amd, prediction